Eczema Research Study (Oral + Topical)

Adolescents and adults aged 12-75 years old with chronic eczema (atopic dermatitis), may qualify to participate. Individuals must have moderate to severe disease, involving 10% of their body surface area, with an onset of symptoms at least 3 years prior to study start. A history (within 6 months) of inadequate response to treatment with topical medications or systemic treatment, is also required.

Participants will receive investigational oral medication (active study drug) or placebo during the initial treatment period, combined with topical corticosteroids. During the extension period, those individuals who previously received placebo will receive active study drug, combined with topical corticoteroids. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 34 months and involve about 20 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more